These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18358571)

  • 41. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
    Aygül A
    Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in silico studies of chalcones derived from natural acetophenone inhibitors of NorA and MepA multidrug efflux pumps in Staphylococcus aureus.
    Freitas TS; Xavier JC; Pereira RLS; Rocha JE; Campina FF; de Araújo Neto JB; Silva MMC; Barbosa CRS; Marinho ES; Nogueira CES; Dos Santos HS; Coutinho HDM; Teixeira AMR
    Microb Pathog; 2021 Dec; 161(Pt B):105286. PubMed ID: 34793877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenothiazinium-fluoroquinolone drug conjugates.
    Wainwright M; Shah A; Meegan K; Loughran C; Smith A; Valli N; Dempster N
    Int J Antimicrob Agents; 2010 Apr; 35(4):405-9. PubMed ID: 20060690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.
    Sabatini S; Gosetto F; Serritella S; Manfroni G; Tabarrini O; Iraci N; Brincat JP; Carosati E; Villarini M; Kaatz GW; Cecchetti V
    J Med Chem; 2012 Apr; 55(7):3568-72. PubMed ID: 22432682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines.
    Dang Z; Yang Y; Ji R; Zhang S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4523-6. PubMed ID: 17566733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mass spectrometry-based assay for improved quantitative measurements of efflux pump inhibition.
    Brown AR; Ettefagh KA; Todd D; Cole PS; Egan JM; Foil DH; Graf TN; Schindler BD; Kaatz GW; Cech NB
    PLoS One; 2015; 10(5):e0124814. PubMed ID: 25961825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Saiful AJ; Mastura M; Zarizal S; Mazurah MI; Shuhaimi M; Ali AM
    J Basic Microbiol; 2008 Aug; 48(4):245-51. PubMed ID: 18720500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A; Felicetti T; Iraci N; Manfroni G; Massari S; Pietrella D; Tabarrini O; Kaatz GW; Barreca ML; Sabatini S; Cecchetti V
    J Med Chem; 2017 Feb; 60(4):1598-1604. PubMed ID: 28117588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An instrument-free method for the demonstration of efflux pump activity of bacteria.
    Martins M; Santos B; Martins A; Viveiros M; Couto I; Cruz A; Pagès JM; Molnar J; Fanning S; Amaral L; ; ;
    In Vivo; 2006; 20(5):657-64. PubMed ID: 17091774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Essential Oil, Extracts, and Sesquiterpenes Obtained From the Heartwood of
    Espinoza J; Urzúa A; Sanhueza L; Walter M; Fincheira P; Muñoz P; Mendoza L; Wilkens M
    Front Microbiol; 2019; 10():337. PubMed ID: 30863385
    [No Abstract]   [Full Text] [Related]  

  • 51. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
    Opperman TJ; Williams JD; Houseweart C; Panchal RG; Bavari S; Peet NP; Moir DT; Bowlin TL
    Bioorg Med Chem; 2010 Mar; 18(6):2123-2130. PubMed ID: 20188576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial resistance modifying tetrasaccharide agents from Ipomoea murucoides.
    Chérigo L; Pereda-Miranda R; Gibbons S
    Phytochemistry; 2009 Jan; 70(2):222-7. PubMed ID: 19136125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.
    Rouveix B
    J Antimicrob Chemother; 2007 Jun; 59(6):1208-9. PubMed ID: 17507420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins.
    Costa LM; de Macedo EV; Oliveira FA; Ferreira JH; Gutierrez SJ; Peláez WJ; Lima FC; de Siqueira Júnior JP; Coutinho HD; Kaatz GW; de Freitas RM; Barreto HM
    J Appl Microbiol; 2016 Nov; 121(5):1312-1322. PubMed ID: 27537678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
    Chérigo L; Pereda-Miranda R; Fragoso-Serrano M; Jacobo-Herrera N; Kaatz GW; Gibbons S
    J Nat Prod; 2008 Jun; 71(6):1037-45. PubMed ID: 18500841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent updates of fluoroquinolones as antibacterial agents.
    Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein.
    Kaatz GW; DeMarco CE; Seo SM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1276-81. PubMed ID: 16569840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial efflux pump inhibitors from natural sources.
    Stavri M; Piddock LJ; Gibbons S
    J Antimicrob Chemother; 2007 Jun; 59(6):1247-60. PubMed ID: 17145734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chalcones Isolated from
    Rezende-Júnior LM; Andrade LMS; Leal ALAB; Mesquita ABS; Santos ALPAD; Neto JSL; Siqueira-Júnior JP; Nogueira CES; Kaatz GW; Coutinho HDM; Martins N; da Rocha CQ; Barreto HM
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32575738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.